How I Am Using CDK4/6 Inhibitors for My Patients With Hormone Receptor –Positive MBC

Discussion - Are you considering CDK4/6 inhibitors as part of your treatment armamentarium for patients with hormone receptor –positive metastatic breast cancer? Dr. Jahanzeb provides insights from his experience.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research